000 01892cam a2200481 i 4500
001 ocn953174282
003 OCoLC
005 20170826160830.0
006 m o d f
007 cr mn|||||||||
008 160707s1997 dcua ob f000 0 eng c
040 _aGPO
_beng
_erda
_epn
_cGPO
_dOCLCF
_dGPO
042 _apcc
043 _an-us---
074 _a0445-B-07 (online)
086 0 _aHE 1.75:OEI-06-96-00082
088 _aOEI-06-96-00082
099 _aHE 1.75:OEI-06-96-00082
110 1 _aUnited States.
_bDepartment of Health and Human Services.
_bOffice of Inspector General,
_eauthor.
245 1 0 _aPrescription drug use In nursing homes.
_nReport 3,
_pA pharmaceutical review and Inspection recommendations.
246 3 0 _aPharmaceutical review and Inspection recommendations
264 1 _a[Washington, D.C.] :
_bDepartment of Health and Human Services, Office of Inspector General,
_c1997.
300 _a1 online resource ([88] pages) :
_billustrations
337 _2rdamedia
338 _2rdacarrier
500 _aTitle from title screen (viewed July 7, 2016).
500 _a"November 1997."
500 _a"OEI-06-96-00082."
500 _aCRDP Project record.
504 _aIncludes bibliographical references (pages 18-20).
650 0 _aNursing home patients
_zUnited States.
650 0 _aDrugs
_zUnited States.
650 0 _aNursing homes
_xPharmaceutical services.
650 0 _aNursing home care
_zUnited States.
650 7 _aDrugs.
_2fast
_0(OCoLC)fst00898761
650 7 _aNursing home care.
_2fast
_0(OCoLC)fst01041902
650 7 _aNursing home patients.
_2fast
_0(OCoLC)fst01041924
650 7 _aNursing homes
_xPharmaceutical services.
_2fast
_0(OCoLC)fst01042016
651 7 _aUnited States.
_2fast
_0(OCoLC)fst01204155
856 4 0 _uhttp://purl.fdlp.gov/GPO/gpo69539
949 _aBEV
_bFed Docs
942 _c3
999 _c265396
_d265396